Idera Pharmaceuticals Announces Financial Results for the 3 and 9 Months Ended 9/30/2006
14th Nov 2006, 16:19 GMT
Idera Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics targeting Toll-like Receptors, reported financial results for the 3 and 9 months ended 9/30/2006.
Idera Pharmaceuticals Announces Financial Results for the 3 and 9 Months Ended 9/30/2006 related news:
- Symbollon Pharmaceuticals Announces Third Quarter 2006 Results — ArriveNet : Health
- Symbollon Pharmaceuticals, Inc.: Symbollon Pharmaceuticals Announces Third Quarter 2006 Results — Market Wire - Pharmaceuticals and Biotech
- BioSante Pharmaceuticals Reports Q3 2006 Financial Results And Reviews Bio-E-Gel Marketing Agreement — Operations-Related News from StratCenter.com
- IDM Pharma Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Antares Pharma Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006 — ArriveNet : Health
- Inflazyme Pharmaceuticals Ltd.: Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006 — Market Wire - Pharmaceuticals and Biotech
- Jerini Reports Financial Results for First Nine Months — ArriveNet : Press Releases
- Eurogas Corporation Announces Third Quarter Financial Results — ArriveNet : Business
- Neurologix Announces Q3 Results — Neurology News from StratCenter.com
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies